David Fruhling

David Fruhling is a highly experienced Senior Scientist in the field of Biomarker Discovery. With a background in Oncology Research and Molecular Biology, David has held various scientist positions at pharmaceutical companies such as Pfizer, Boehringer Ingelheim, and Cadus. David obtained a BS in Biology from Stony Brook University in 1989.